Composition
- Active ingredients
- CILASTATIN SODIUM EQ 250MG BASE/VIAL; IMIPENEM 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CILASTATIN SODIUM EQ 250MG BASE/VIAL; IMIPENEM 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · PowderThis page
- CILASTATIN SODIUM EQ 500MG BASE/VIAL; IMIPENEM 500MG/VIAL · PowderNDA050587-002 · Prescription
- CILASTATIN SODIUM EQ 250MG BASE/VIAL; IMIPENEM 250MG/VIAL · InjectableANDA062756-001 · Discontinued
- CILASTATIN SODIUM EQ 500MG BASE/VIAL; IMIPENEM 500MG/VIAL · InjectableANDA062756-002 · Discontinued
- CILASTATIN SODIUM EQ 500MG BASE/VIAL; IMIPENEM 500MG/VIAL · PowderNDA050630-001 · Discontinued
- CILASTATIN SODIUM EQ 750MG BASE/VIAL; IMIPENEM 750MG/VIAL · PowderNDA050630-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050587.
At a glance
- Brand name
- Primaxin
- Active substance
- cilastatin sodium
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Merck
- Status
- Discontinued
- FDA approval
- 26 Nov 1985
- Application
- NDA050587-001